Novartis AG Sponsored ADR Logo

Novartis AG Sponsored ADR (0K9E)

LSE

Currency in USD
140.79
+0.62 (+0.44%)

Real-time Data

07:00 AM

Day's Range

140.00
142.52

52 wk Range

121.65
170.29

Overview - 0K9E - Novartis AG Sponsored ADR

Key Statistics

Valuation

Enterprise Value

314.49B

P/E (Trailing)

‪0.13‬

Price / Book

‪6.60‬

EV / EBITDA

‪13.61‬

Profitability

Profit Margin

‪22.50%‬

Operating Margin

‪34.62%‬

Return on Assets

‪10.25%‬

Return on Equity

‪30.35%‬

Ownership

Shares Outstanding

2.30B

Float

1.85B

Held by Insiders

‪0.01%‬

Held by Institutions

‪7.26%‬

Price stats

Beta

‪0.49‬

50-Day Avg

‪103.84‬

200-Day Avg

‪100.29‬

Dividends

Frequency

Annual

News Teaser - 0K9E - Novartis AG Sponsored ADR

News & Analysis

View all news

Market Cap - 0K9E - Novartis AG Sponsored ADR

Peers - 0K9E - Novartis AG Sponsored ADR

Peer Comparison

Compared with companies in Drug Manufacturers - General listed on LSE.

Profile Summary - 0K9E - Novartis AG Sponsored ADR

About

Novartis AG Sponsored ADR represents Novartis AG, a global healthcare company focused on developing, manufacturing, and commercializing prescription medicines and related healthcare products. Novartis serves major therapeutic areas including oncology, immunology, cardiovascular, neuroscience, and ophthalmology, with a…

SectorHealthcare
IndustryDrug Manufacturers - General
Employees75.26K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.